Bausch & Lomb Inc. appears to be on the market. The Wall Street Journal and Bloomberg report the company has hired investment bank Goldman Sachs Group Inc. to explore a sale after receiving informal expressions of interest from several large health care companies. The articles cite unnamed people familiar with the matter.
The eye-care company reportedly is hoping to command a price of at least $10 billion.
Warburg Pincus LLC bought the Rochester company for $3.7 billion in September 2007, taking the longtime publicly traded company private. Bausch & Lomb leaders this year indicated its goal to go public again.
Bloomberg reported Goldman this month contacted health care companies such as Sanofi, GlaxoSmithKline PLC and Merck & Co. Other companies, such as Abbott Laboratories, are expected to be contacted.
(c) 2012 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail email@example.com.